Filter
475
Text search:
Disposal
of
Goods
Featured
Recommendations
45
New Publications
145
Language
Document type
No document type
276
Guidelines
67
Studies & Reports
61
Strategic & Response Plan
29
Manuals
28
Situation Updates
6
Fact sheets
4
Training Material
2
Brochures
1
Infographics
1
Countries / Regions
Kenya
30
Global
21
Uganda
19
Liberia
17
India
17
Nigeria
14
Myanmar / Burma
14
Sierra Leone
12
Ethiopia
12
Nepal
12
Syria
12
Ghana
9
Philippines
8
Bangladesh
7
Lesotho
7
Zambia
6
Tanzania
6
Rwanda
6
Zimbabwe
5
South Sudan
5
Ukraine
5
Latin America and the Carribbean
5
Guinea
4
Senegal
4
Pakistan
4
Jordan
4
Cambodia
4
South Africa
4
Mozambique
4
Namibia
4
Congo, Democratic Republic of
3
Lebanon
3
Malawi
3
Eswatini/ Swaziland
3
Botswana
3
Western Pacific Region
3
Western and Central Europe
3
Africa
3
Haiti
2
Somalia
2
Iraq
2
Germany
2
Egypt
2
Papua New Guinea
2
Central African Republic
2
Yemen
2
West and Central Africa
2
Middle East and North Africa
2
Venezuela
2
Palestine
2
Mali
1
USA
1
Cameroon
1
Afghanistan
1
Turkey
1
Indonesia
1
Singapore
1
Sudan
1
Croatia
1
Burundi
1
East and Southern Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Fiji
1
Eastern Europe
1
Albania
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Moldova
1
Vietnam
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
224
Key Resources
37
Public Health
18
Clinical Guidelines
17
Women & Child Health
13
Pharmacy & Technologies
13
Capacity Building
10
Toolboxes
COVID-19
50
Planetary Health
29
Conflict
24
Pharmacy
22
Ebola
21
Rapid Response
21
HIV
15
Natural Hazards
14
AMR
10
Specific Hazards
9
Health Financing Toolbox
9
Mental Health
8
Caregiver
8
Cholera
6
Social Ethics
5
Disability
4
Global Health Education
4
Polio
3
Refugee
3
NTDs
2
NCDs
2
TB
1
Health Financing
1
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste
...
Wet markets have been implicated in multiple zoonotic outbreaks, including COVID-19. They are also a conduit for legal and illegal trade in wildlife, which threatens thousands of species. Yet wet markets supply food to millions
...
Recognizing the importance of the critical role of community health in disaster management, the Amref health Africa has
developed this operational guide to provide policy direction on COVID-19 resp
...
It is too early to know the full impact of COVID-19 on Africa. To date the experience has been varied. There are causes for concern, but also reasons for hope. Early estimates were pessimistic regarding the pandemic’s impact on the continent. But
...
This guidance note on Syria is the first in a series of comprehensive Q&As, which aims to give practical guidance on how to comply with EU sanctions when providing humanitarian aid, in particular medical assistance, to fight the coronavirus pandemic
...
Development assistance for health (DAH) is an important part of financing healthcare in low- and middle-income countries. We estimated the gross disbursement of DAH
...
A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On March 11, the World Health Organization (WHO) decl
...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G
...
Accessed 15th of October 2015
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon
...
This report looks at how the current implications of COVID-19 is exacerbating key challenges for people who menstruate around the world and provides recommendations on how to include menstrual hygiene management (MHM) within a COVID-19 response.
COVID-19: Travel, Points of Entry and Border Health
The COVID-19 pandemic has had an unprecedented impact on health care systems that, in many instances, worsened the already existing assistance gaps. When it comes to Latin America and Central America, this challenge adds to the consequences mass mobilizations have had in recent years, which have exc
...
Page visited January 2019, publication date unknown.
Patients with suspected coronavirus disease 2019 (COVID-19) can infect others at any time, including during transfer and transport. COVID-19 is a new infectious disease that requires contact and droplet precautions; lapses in infection prevention and control (IPC) can easily happen at vulnerable mom
...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon
...
